The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Google Chrome
Safari
Firefox
Edge
© 2025 Hovione
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
search
    en
      pt jp cn
Hovione
Home Go up
  • Products and Services
      • Contract Manufacturing Services
        • Drug Substance
        • Particle Engineering
        • Drug Product
      • Off-patent API products
        • API Portfolio
        • Exclusive partnerships
        • High value applications
      • Supporting Capabilities
        • Analytical Support
        • Capabilities
        • Continuity of Supply
        • Quality and Compliance
  • Knowledge Center
  • About Us
      • About Hovione
        • What we do
        • Management
        • Sustainability
        • History
  • Contact Us
  • Press Room
  • Hovione Worldwide
  • Careers
  • Restricted Area

Search

Types

  • Article

Press Room

  • (-) Article

Categories

  • PE - Particle Engineering
  • About Hovione
  • PE - Spray drying
  • Compliance
  • DP - Inhalation formulation
  • Contract Manufacturing Services
  • PE - Inhalable particles
  • Quality
  • DP - Drug product
  • Hovione New Jersey
  • Off-patent API
  • Manufacturing
  • cGMP
  • Homepage
  • Hovione Cork
  • Hovione Loures
  • DP - DPI devices
  • DS - Drug Substance
  • Hovione Lumiar
  • Hovione Mumbai
  • PAT
  • PE - Drug delivery platforms
  • DP - Formulation of amorphous systems
  • Hovione Japan
  • Management
  • PE - Solubility enhancement
  • Analytical support
  • Continuous Manufacturing
  • Hovione Macau
  • PE - Hot melt extrusion
  • PE - Process development & scale-up
  • Suporting capabilities
  • Devices
  • Enhanced Process Understanding
  • Hovione China
  • Methodologies
  • QbD
  • CMO
  • Continuous Manufacturing
  • Continuous Tableting
  • Development by Design
  • DP - Capsule filling
  • DP - Oral Dosage Form
  • DPI
  • DS - Scale-down modeling
  • Generics
  • PE - Spray congealing
  • PPL - Proprietary Product Licensing
View
Article / Mar 01, 2025

SPECIAL FEATURE - Bioavailability & Solubility: The Promise of Novel Ingredients

Drug Development & Delivery, 01 March 2025

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 14
  • Page 15
  • Page 16
  • Current page 17
Analytical Support
Quality and Compliance
Capabilities
Continuity of Supply
Track Record/cGMP Compliance
Regulatory Affairs
Continuity of Supply
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
Contacts
Lindenstrasse 14
6340 Baar
Switzerland
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • Privacy Notice
  • Terms and Conditions
    • Linkedin
    • Facebook
    • Twitter
    • Instagram
    • Youtube
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
  • Contacts
    Lindenstrasse 14
    6340 Baar
    Switzerland
    © 2025 Hovione
    © 2025 Hovione
    • Privacy Notice
    • Terms and Conditions